The FDA has rejected Lykos Therapeutics’ New Drug Application for MDMA-assisted therapy for PTSD and requested an additional Phase 3 study.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
FOR IMMEDIATE RELEASE: August 9, 2024| Multidisciplinary Association for Psychedelic Studies - MAPS